Disruption of the actin cytoskeleton results in nuclear factor‐κB activation and inflammatory mediator production in cultured human intestinal epithelial cells
暂无分享,去创建一个
Csaba Szabo | Edwin A. Deitch | E. Vizi | C. Szabó | E. Deitch | G. Haskó | Z. Nemeth | E. Sylvester Vizi | György Haskó | Zoltán H. Németh | Marson T. Davidson | M. Davidson
[1] R. Juliano,et al. Integrin Signaling , 2005, Cancer and Metastasis Reviews.
[2] Vitold E. Galkin,et al. The p65/RelA Subunit of NF-κB Interacts with Actin-Containing Structures , 2000 .
[3] Samuel E. Lux,et al. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins , 1990, Nature.
[4] C. Fiorentini,et al. Bacteroides fragilis enterotoxin induces cytoskeletal changes and surface blebbing in HT-29 cells , 1996, Infection and immunity.
[5] J. Cooper,et al. Effects of cytochalasin and phalloidin on actin , 1987, The Journal of cell biology.
[6] Dan He,et al. Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. , 2002, Gastroenterology.
[7] D. Brenner,et al. Cellular Differentiation Causes a Selective Down-regulation of Interleukin (IL)-1β-mediated NF-κB Activation and IL-8 Gene Expression in Intestinal Epithelial Cells* , 2000, The Journal of Biological Chemistry.
[8] Shaoguang Wu,et al. Bacteroides fragilis toxin rearranges the actin cytoskeleton of HT29/C1 cells without direct proteolysis of actin or decrease in F-actin content. , 1997, Cell motility and the cytoskeleton.
[9] L. Harrison,et al. Phenylbutyrate-induced apoptosis is associated with inactivation of NF-κB IN HT-29 colon cancer cells , 2001, Cancer Chemotherapy and Pharmacology.
[10] C. Pothoulakis,et al. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. , 1988, The Journal of clinical investigation.
[11] P. Baeuerle. IκB–NF-κB Structures At the Interface of Inflammation Control , 1998, Cell.
[12] C. Szabó,et al. Na+/H+ exchanger blockade inhibits enterocyte inflammatory response and protects against colitis. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[13] P. Zhu,et al. Regulation of interleukin 1 signalling through integrin binding and actin reorganization: disparate effects on NF-kappaB and stress kinase pathways. , 1998, The Biochemical journal.
[14] J. M. Kim,et al. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. , 1999, Journal of immunology.
[15] S. Kassis,et al. p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials. , 1999, Pharmacology & therapeutics.
[16] D. Podolsky,et al. Lipopolysaccharide Activates Distinct Signaling Pathways in Intestinal Epithelial Cell Lines Expressing Toll-Like Receptors1 , 2000, The Journal of Immunology.
[17] F. Braet,et al. New anti‐actin drugs in the study of the organization and function of the actin cytoskeleton , 1999, Microscopy research and technique.
[18] M. Karin,et al. The IKK/NF-kappa B pathway. , 2002 .
[19] J. Madara,et al. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity , 1986, The Journal of cell biology.
[20] D. Green,et al. The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .
[21] C. Szabó,et al. Lithium Induces NF-κB Activation and Interleukin-8 Production in Human Intestinal Epithelial Cells* , 2002, The Journal of Biological Chemistry.
[22] N. Leclerc,et al. I kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domain , 1997, Molecular and cellular biology.
[23] S. Haskill,et al. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. , 1997, Journal of immunology.
[24] D. Braguer,et al. Involvement of nuclear factor kappaB in c-Myc induction by tubulin polymerization inhibitors. , 2001, Molecular pharmacology.
[25] A. Keshavarzian,et al. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor α in a human colonic cell line , 2000, Gut.
[26] Michael Karin,et al. Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.
[27] L. Norton,et al. Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2 , 2000, The Journal of Biological Chemistry.
[28] S. Erlandsen,et al. Cytochalasin-Induced Actin Disruption of Polarized Enterocytes Can Augment Internalization of Bacteria , 1998, Infection and Immunity.
[29] V. Bennett,et al. Brain ankyrin. A membrane-associated protein with binding sites for spectrin, tubulin, and the cytoplasmic domain of the erythrocyte anion channel. , 1984, The Journal of biological chemistry.
[30] J. Inoue,et al. The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IkappaBalpha. , 1996, Oncogene.
[31] C. Szabó,et al. Hyperosmotic stress induces nuclear factor-kappaB activation and interleukin-8 production in human intestinal epithelial cells. , 2002, The American journal of pathology.
[32] D. Green,et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. , 2002, Immunity.
[33] Z. Werb,et al. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. , 1998, Science.
[34] M. Aschner,et al. Cellular and molecular effects of trimethyltin and triethyltin: Relevance to organotin neurotoxicity , 1992, Neuroscience & Biobehavioral Reviews.
[35] Cytoskeletal Control of Gene Expression : Depolymerization of Microtubules Activates NF-xB , 2002 .
[36] S. Erlandsen,et al. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium. , 1999, Archives of surgery.
[37] Avri Ben-Ze've. Animal cell shape changes and gene expression , 1991 .
[38] E. Chang,et al. Heat-shock protein 72 protects against oxidant-induced injury of barrier function of human colonic epithelial Caco2/bbe cells. , 1999, Gastroenterology.
[39] S. Savkovic,et al. Activation of NF-κB in intestinal epithelial cells by enteropathogenic Escherichia coli. , 1997, American journal of physiology. Cell physiology.
[40] E. Frixione. Recurring views on the structure and function of the cytoskeleton: a 300-year epic. , 2000, Cell motility and the cytoskeleton.
[41] S. Savkovic,et al. Activation of NFk B in intestinal epithelial cells by enteropathogenic Escherichia coli , 1997 .
[42] R. Davis,et al. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. , 1997, Journal of immunology.
[43] E. Corsini,et al. NF-κB Activation by Triphenyltin Triggers Apoptosis in HL-60 Cells , 1996 .
[44] A. Ben-Ze'ev. Animal cell shape changes and gene expression. , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.
[45] T. Murayama,et al. [Molecular mechanism of interleukin-8 gene expression]. , 1994, Rinsho byori. The Japanese journal of clinical pathology.
[46] M. Karin,et al. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B , 1995, The Journal of cell biology.
[47] K. Lundin,et al. Cytokine profiles of cultured microvascular endothelial cells from the human intestine , 1998, Gut.
[48] A. Israël,et al. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats , 1992 .
[49] Evidence That Nuclear Factor-κB Activation Is Critical in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Integrity and That Its Inactivation Is Essential in Epidermal Growth Factor-Mediated Protection of the Monolayers of Intestinal Epithelia , 2003, Journal of Pharmacology and Experimental Therapeutics.